Evidence map›Paper›PMID 28314621›Full record

ReviewProstaglandins, leukotrienes, and essential fatty acids2018

Docosahexaenoic acid (DHA): An essential nutrient and a nutraceutical for brain health and diseases.

Grace Y Sun, Agnes Simonyi, Kevin L Fritsche, Dennis Y Chuang, Mark Hannink, Zezong Gu, C Michael Greenlief, Jeffrey K Yao, James C Lee, David Q Beversdorf

Open access · greenAbstract readReview
In one paragraph

Review in Prostaglandins, leukotrienes, and essential fatty acids, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 136 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
136citing papers in PubMed, 5 pooled it
15.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

136 citing papers in PubMed, 5 syntheses or guidelines pooled it, 298 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Trial
  7. Trial
  8. Trial
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article

76 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Grace Y SunBiochemistry Department, University of Missouri, Columbia, MO, United States.
Agnes SimonyiBiochemistry Department, University of Missouri, Columbia, MO, United States.
Kevin L FritscheDepartment of Nutrition and Exercise Physiology, University of Missouri, Columbia, MO, United States.
Dennis Y ChuangDepartment of Neurology, University Hospitals Cleveland Medical Center and Case Western Reserve University, Cleveland, OH, United States.
Mark HanninkBiochemistry Department, University of Missouri, Columbia, MO, United States.
Zezong GuDepartment of Pathology and Anatomical Sciences, University of Missouri School of Medicine, Columbia, MO, United States.
C Michael GreenliefChemistry Department, University of Missouri, Columbia, MO, United States.
Jeffrey K YaoMedical Research Service, VA Pittsburgh Healthcare System, and Department of Psychiatry, University of Pittsburgh School of Medicine, Pittsburgh, PA, United States.
James C LeeDepartment of Bioengineering, University of Illinois at Chicago, Chicago, IL, United States.
David Q BeversdorfDepartment of Radiology, Neurology, and Psychological Sciences, and the Thompson Center, William and Nancy Thompson Endowed Chair in Radiology, University of Missouri School of Medicine, Columbia, MO, United States.
University of Missouri · USUniversity Hospitals of Cleveland · USUniversity of Illinois Chicago · USUniversity of Pittsburgh · US

Funding

Roles of Tau Oligomers in Alzheimer's VasculopathyR01AG044404 · NIA · UNIVERSITY OF MISSOURI-COLUMBIA · PI LEE, JAMES C · 2014 to 2024
$3.5M
NIA NIH HHS R01 AG044404
6 · The paper itself

Abstract

Docosahexaenoic acid (DHA), a polyunsaturated fatty acid (PUFA) enriched in phospholipids in the brain and retina, is known to play multi-functional roles in brain health and diseases. While arachidonic acid (AA) is released from membrane phospholipids by cytosolic phospholipase A

Indexed as

AgingAnimalsBrainDietary SupplementsDocosahexaenoic AcidsGroup VI Phospholipases A2HumansMental DisordersNeuroprotective AgentsDocosahexaenoic AcidsGroup VI Phospholipases A2Neuroprotective AgentsPLA2G6 protein, human4-hydoxyhexenal (4-HHE)Alox 15Antioxidant response element (ARE)Brain-derived neurotropic factor (BDNF)Brain developmentDocosahexaenoic acid (DHA)Heme oxygenase-1 (HO-1)IPLA(2)Life spectrumNeuroinflammationNeuroprotectin 1 (NPD1)Nuclear factor (erythroid-derived 2)-like 2 (Nrf2)Nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB)Oxidative metabolitesOxylipinsPolyunsaturated fatty acids (PUFA)ResolvingSignaling pathways

Identifiers

PMID28314621
PMCPMC9087135
OpenAlexW2594707478

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.